Skip to main content
. 2013 Jun 24;5(5):711–722. doi: 10.4161/mabs.25488

Table 5. LC-MSE Data for Amino Acid Residue Variations between Heavy Chains A and B.

variable site(s)a peptide RT (min) sequence   theoretical mass (Da)b measured mass (Da) mass error (ppm) intensity (counts)
354
HCA:T33–35c
44.1
GQPREPQVYVYPPSRDELTK
 
2358.1968
2358.1931
-1.6
116764
HCB:T33–35c
47.4
GQPREPQVYVLPPSRDELTK
 
2308.2175
2308.2158
-0.7
119682
369
HCA:T36
48.0
NQVSLTCLVK
 
1160.6223
1160.6239
1.4
226906
HCB:T36
58.6
NQVSLLCLVK
 
1172.6588
1172.6610
1.9
244944
395, 397, 408, 410 HCA:T37 (1)d
55.9
GFYPSDIAVEWESNGQPENNYK
 
2543.1240
2543.1230
-0.4
175028
HCA:T38 (2)d
54.8
TTPPVLDSDGSFALVSK
 
1732.8883
1732.8901
1.0
264347
HCB:T37d 81.4 GFYPSDIAVEWESNGQPENNYLTWPPVLDSDGSFFLYSK   4468.0488 4468.0439 -1.1 172680

a. Numbering is based on the trastuzumab sequence. b. Mass corresponds to carbamidomethylated cysteines. c. A hyphen in the peptide number indicates miscleavage. d. The lysine at position 395 of HCa is a trypsin cleavage site, leading to the two tryptic peptides T37 and T38. Position 395 in HCb is a leucine, which is not a trypsin cleavage site. Therefore, the same amino acid range in HCb only leads to one tryptic peptide T37.